Practice Contact Information
6420 Rockledge Drive, Suite 4920
Areas of Interest in Head and Neck Surgery
Head and Neck Research, Head and Neck Surgeon
Dr. Nicole Schmitt is a fellowship-trained head and neck cancer surgeon. Her clinical interests include surgical treatment and surveillance of patients with benign and malignant tumors of the head and neck, robotic surgery, benign and malignant thyroid and parathyroid disease, and skin cancers of the head and neck. Dr. Schmitt’s research interests include the use of platinum-based chemotherapy drugs and immunotherapy for the treatment of head and neck cancer. She holds a joint appointment at the National Institutes of Health.
Dr. Schmitt earned her medical degree from the Washington University School of Medicine in St. Louis, Missouri, and completed her residency training in otolaryngology at the University of Washinton in Seattle, Washington. Dr. Schmitt also completed a head and neck surgical oncology fellowship at the University of Pittsburgh.
Gilbert MR, Sharma A, Schmitt NC, Johnson JT, Ferris RL, Duvvuri U, Kim SW. Salivary Duct Carcinoma: A Single-Institution, 20-Year Review of 75 Cases. JAMA Otolaryngol 2015; in press.
Hodnett BL, Schmitt NC, Thirumala PD, Duvvuri U. Intraoperative Identification of the Human Communicating Nerve during Thyroidectomy. J Surg Case Rep 2015, in press.
Schmitt NC, Sharma A, Gilbert MR, Kim S. Early T stage salivary duct carcinoma: Outcomes and implications for patient counseling. Otolaryngol Head Neck Surg 2015; pii: 0194599815601659.
Kansy BA, Schmitt NC, Ferris RL. Immune escape and immunotherapy of HPV-related oropharyngeal carcinoma: Has the future arrived? Curr Otorhinolaryngol Rep 2015; doi: 10.1007/s40136-015-0079-8
Schmitt NC, Ferris RL. STAT1 activation is enhanced by cisplatin and variably affected by EGFR inhibition in HNSCC cells. Mol Cancer Ther. 2015; pii: molcanther.0305.2015.
Mitchell RM, Mendez E, Schmitt NC, Bhrany AD, Futran ND. Antibiotic prophylaxis in patients receiving free flap reconstruction. JAMA Otolaryngol 2015; doi:10.1001/jamaoto.2015.0513.
Schmitt NC, Duvvuri U. Transoral robotic surgery for oropharyngeal squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg 2015; 23: 127-131.
Trivedi S, Concha-Benavente F, Srivastava RM, Jie HB, Gibson SP, Schmitt NC, Ferris RL. Immune biomarkers of anti-EGFR monoclonal antibody therapy in squamous cell carcinomas of the head and neck. Ann Oncol 2014; 26:40-47.
Hodnett BL, Schmitt NC, Clayburgh DR, Burkowsky A, Balzer J, Thirumala PD, Duvvuri U. Superior Laryngeal Nerve Monitoring using Laryngeal Surface Electrodes and Intraoperative Neurophysiological Monitoring. Clin Anat 2014; 28:460-466.
Schmitt NC, Rubel EW. ?Osteopontin does not mitigate cisplatin ototoxicity or nephrotoxicity in adult mice. ?Otolaryngol Head Neck Surg 2013; 149:614-620.
Hsia JC, Schmitt NC, Hoch B, Moe KS. ? Pathology quiz case: Laryngeal rhabdomyosarcoma, embryonal subtype. ? Arch Otolaryngol Head Neck Surg 2011; 137:635 & 638-639.
Schmitt NC, Rubel EW, Nathanson NM. ? Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate. ? J Neurosci 2009; 29:3843-3851.